<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37051301</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Short-term prognostic analysis of patients with systemic lupus erythematosus co-infection and comparison of mNGS and conventional microbiological test results.</ArticleTitle><Pagination><StartPage>1131258</StartPage><MedlinePgn>1131258</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1131258</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2023.1131258</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Infection is one of the major causes of morbidity and mortality in patients with systemic lupus erythematosus (SLE), and as a new diagnostic technique, metagenomic next-generation sequencing (mNGS) is increasingly used for the pathogenetic detection of co-infected SLE patients. However, conventional microbiological testing (CMT) is still the gold standard for pathogenic diagnosis, and the specific diagnostic efficacy of mNGS versus CMT in such patients is not known. In addition, there are few studies on the short-term prognosis of co-infected SLE patients.</AbstractText><AbstractText Label="METHODS">This study retrospectively included 58 SLE patients with co-infection admitted to the First Affiliated Hospital of Zhengzhou University from October 2020 to August 2022. Patients were divided into a survivors (n=27) and a non-survivors (n=31) according to their discharge status. Baseline characteristics and etiological data were collected and statistically analyzed for all patients during their hospitalization. The sequential organ failure assessment (SOFA) score, acute physiology and chronic health evaluation (APACHE) II and systemic lupus erythematosus disease activity index (SLEDAI) were calculated for each patient to assess the predictive ability of the 3 scores on the short-term prognosis of SLE patients. The mNGS and CMT culture results were also compared to clarify the flora characteristics of patients with SLE infection.</AbstractText><AbstractText Label="RESULTS">More patients in the non-survivors had renal impairment, neurological manifestations, multiplasmatic cavity effusion and gastrointestinal manifestations compared to the survivors (p &lt; 0.05). The SOFA score, APACHE II and SLEDAI were significantly higher in the non-survivors than in the survivors (p &lt; 0.01). There were also significant differences between the two groups in several tests such as hemoglobin, platelets, albumin, total bilirubin, C-reactive protein (CRP), procalcitonin (PCT), and complement C3 (p &lt; 0.05). In addition, the absolute values of T lymphocytes, CD4+ T cells and CD8+ T cells were smaller in the non-survivors than in the survivors (p &lt; 0.05). The most common type of infection in this study was pulmonary infection, followed by bloodstream infection. mNGS and CMT positivity rates were not significantly different among patients in the non-survivors, but were significantly different among patients in the survivors (p=0.029). In-hospital survival of patients with SLE infection could be predicted based on the SOFA score in relation to 6. For patients with SOFA &lt;6, we recommend earlier mNGS testing to identify the pathogen and improve patient prognosis.</AbstractText><AbstractText Label="CONCLUSIONS">For SLE patients with co-infection, in-hospital survival can be predicted based on SOFA score. For patients with SOFA &lt;6, advising them to complete mNGS testing as early as possible may improve the prognosis to some extent.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Zhao, Duan, Lu, Bai and Zhao.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center, Henan Key Laboratory of Hereditary Cardiovascular Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Ming-Xuan</ForeName><Initials>MX</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center, Henan Key Laboratory of Hereditary Cardiovascular Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yan-Yu</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center, Henan Key Laboratory of Hereditary Cardiovascular Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Lin-Peng</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center, Henan Key Laboratory of Hereditary Cardiovascular Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xiao-Yan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center, Henan Key Laboratory of Hereditary Cardiovascular Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">conventional microbiological testing</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">metagenomic next-generation sequencing</Keyword><Keyword MajorTopicYN="N">short-term prognosis</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>2</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37051301</ArticleId><ArticleId IdType="pmc">PMC10083406</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2023.1131258</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bosch X., Guilabert A., Pallar&#xe9;s L., Cerveral R., Ramos-Casals M., Bov&#xe9; A., et al. . (2006). Infections in systemic lupus erythematosus: A prospective and controlled study of 110 patients. Lupus 15 (9), 584&#x2013;589. doi:&#xa0;10.1177/0961203306071919</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203306071919</ArticleId><ArticleId IdType="pubmed">17080913</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC (2019). CDC/NHSN surveillance definitions for specific types of infections. Surveillance Definitions 17, 1&#x2013;29.</Citation></Reference><Reference><Citation>Cervera R., Khamashta M. A., Hughes G. R. (2009). The Euro-lupus project: Epidemiology of systemic lupus erythematosus in Europe. Lupus 18 (10), 869&#x2013;874. doi:&#xa0;10.1177/0961203309106831</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309106831</ArticleId><ArticleId IdType="pubmed">19671784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Zhang Y., Zheng J., Shi L., He Y., Niu Y., et al. . (2022). Application of mNGS in the etiological diagnosis of thoracic and abdominal infection in patients with end-stage liver disease. Front. Cell Infect. Microbiol. 11, 1314. doi:&#xa0;10.3389/fcimb.2021.741220</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.741220</ArticleId><ArticleId IdType="pmc">PMC8766839</ArticleId><ArticleId IdType="pubmed">35071029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Haozhu L. G. (2017). Practice of internal medicine. 15th Edition (China: People&#x2019;s Medical Publishing House Co., LTD.).</Citation></Reference><Reference><Citation>Crisp&#xed;n J. C., Kyttaris V. C., Terhorst C., Tsokos G. C. (2010). T Cells as therapeutic targets in SLE. Nat. Rev. Rheumatol 6 (6), 317&#x2013;325. doi:&#xa0;10.1038/nrrheum.2010.60</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2010.60</ArticleId><ArticleId IdType="pmc">PMC2924434</ArticleId><ArticleId IdType="pubmed">20458333</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng M., Wu R., Zhou X., Su Y., Li Y. (2022). Analyses of the clinical and immunological characteristics of patients with lupus erythematosus. Indian J. Dermatol. 67 (2), 205. doi:&#xa0;10.4103/ijd.ijd_942_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijd.ijd_942_20</ArticleId><ArticleId IdType="pmc">PMC9455139</ArticleId><ArticleId IdType="pubmed">36092230</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand V., Lamour A., Devauchelle V., Youinou P., Jamin C. (2000). Fc-gamma receptor reactivity in nonorgan-specific autoimmune diseases. Clin. Rev. Allergy Immunol. 18 (1), 11&#x2013;26. doi:&#xa0;10.1385/CRIAI:18:1:11</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/CRIAI:18:1:11</ArticleId><ArticleId IdType="pubmed">10907104</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Bosis S., Semino M., Rigante D. (2014). Infections and systemic lupus erythematosus. Eur. J. Clin. Microbiol. Infect. Dis. 33 (9), 1467&#x2013;1475. doi:&#xa0;10.1007/s10096-014-2098-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-014-2098-7</ArticleId><ArticleId IdType="pubmed">24715155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman D. D., Hussain F., Ibanez D., Urowitz M. B. (2002). The nature and outcome of infection in systemic lupus erythematosus. Lupus 11 (4), 234&#x2013;239. doi:&#xa0;10.1191/0961203302lu170oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203302lu170oa</ArticleId><ArticleId IdType="pubmed">12043887</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldblatt F., Chambers S., Rahman A., Isenberg D. A. (2009). Serious infections in British patients with systemic lupus erythematosus: Hospitalisations and mortality. Lupus 18 (8), 682&#x2013;689. doi:&#xa0;10.1177/0961203308101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308101019</ArticleId><ArticleId IdType="pubmed">19502263</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarner J., Brandt M. E. (2011). Histopathologic diagnosis of fungal infections in the 21st century. Clin. Microbiol. Rev. 24 (2), 247&#x2013;280. doi:&#xa0;10.1128/CMR.00053-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00053-10</ArticleId><ArticleId IdType="pmc">PMC3122495</ArticleId><ArticleId IdType="pubmed">21482725</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslam D. B. (2021). Future applications of metagenomic next-generation sequencing for infectious diseases diagnostics. J. Pediatr. Infect. Dis. Soc. 10, S112&#x2013;S117. doi:&#xa0;10.1093/jpids/piab107</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piab107</ArticleId><ArticleId IdType="pubmed">34951467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho A., Barr S. G., Magder L. S., Petri M. (2001). A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum 44 (10), 2350&#x2013;2357. doi:&#xa0;10.1002/1529-0131(200110)44:10&lt;2350::aid-art398&gt;3.0.co;2-a</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200110)44:10&lt;2350::aid-art398&gt;3.0.co;2-a</ArticleId><ArticleId IdType="pubmed">11665976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Tao Y., Shao Z., Zheng Y., Zhang R., Yang X., et al. . (2021). A comparisonof blood pathogen detection among droplet digital PCR, metagenomic next generation sequencing, and blood culture in critically ill patients with suspected bloodstream infections. Front. Microbiol. 12, 641202. doi:&#xa0;10.3389/fmicb.2021.641202</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.641202</ArticleId><ArticleId IdType="pmc">PMC8165239</ArticleId><ArticleId IdType="pubmed">34079528</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampf G., V oss A., Scheithauer S. (2020). Inactivation of coronaviruses by heat. J. Hosp Infect. 105 (2), 348&#x2013;349. doi:&#xa0;10.1016/j.jhin.2020.03.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2020.03.025</ArticleId><ArticleId IdType="pmc">PMC7271332</ArticleId><ArticleId IdType="pubmed">32243951</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuyama T., Tsokos G. C., Moulton V. R. (2018). Aberrant T cell signaling and subsets in systemic lupus erythematosus. Front. Immunol. 9, 1088. doi:&#xa0;10.3389/fimmu.2018.01088</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01088</ArticleId><ArticleId IdType="pmc">PMC5967272</ArticleId><ArticleId IdType="pubmed">29868033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul A., Gordon C., Crow M. K., Touma Z., Urowitz M. B., van Vollenhoven R., et al. . (2016). Systemic lupus erythematosus. Nat. Rev. Dis. Primers 2 (1), 16039. doi:&#xa0;10.1038/nrdp.2016.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.39</ArticleId><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambden S., Laterre P. F., Levy M. M., Francois B. (2019). The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit. Care 23 (1), 1&#x2013;9. doi:&#xa0;10.1186/s13054-019-2663-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2663-7</ArticleId><ArticleId IdType="pmc">PMC6880479</ArticleId><ArticleId IdType="pubmed">31775846</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisnevskaia L., Murphy G., Isenberg D. (2014). Systemic lupus erythematosus. Lancet 384 (9957), 1878&#x2013;1888. doi:&#xa0;10.1016/S0140-6736(14)60128-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60128-8</ArticleId><ArticleId IdType="pubmed">24881804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Ma L., Zhang H., Feng L., Yu Y., Zhao Y., et al. . (2022). The comparison of metagenomic next-generation sequencing with conventional microbiological tests for identification of pathogens and antibiotic resistance genes in infectious diseases. Infect. Drug Resist. 15, 6115&#x2013;6128. doi:&#xa0;10.2147/IDR.S370964</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S370964</ArticleId><ArticleId IdType="pmc">PMC9586124</ArticleId><ArticleId IdType="pubmed">36277249</ArticleId></ArticleIdList></Reference><Reference><Citation>Maartens G., Griesel R., Dube F., Nicol M., Mendelson M. (2020). Etiology of pulmonary infections in human immunodeficiency virus-infected inpatients using sputum multiplex real-time polymerase chain reaction. Clin. Infect. Dis. 70 (6), 1147&#x2013;1152. doi:&#xa0;10.1093/cid/ciz332</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz332</ArticleId><ArticleId IdType="pmc">PMC7108142</ArticleId><ArticleId IdType="pubmed">31286137</ArticleId></ArticleIdList></Reference><Reference><Citation>Manderson A. P., Botto M., Walport M. J. (2004). The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22, 431&#x2013;456. doi:&#xa0;10.1146/annurev.immunol.22.012703.104549</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.22.012703.104549</ArticleId><ArticleId IdType="pubmed">15032584</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro-Zarza J. E., Alvarez-Hern&#xe1;ndez E., Casasola-Vargas J. C., Estrada-Castro E., Burgos-Vargas R. (2010). Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus 19 (1), 43&#x2013;48. doi:&#xa0;10.1177/0961203309345776</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309345776</ArticleId><ArticleId IdType="pubmed">19884213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastorino B., Touret F., Gilles M., de Lamballerie X., Charrel R. N. (2020). Heat inactivation of different types of SARS-CoV-2 samples: what protocols for biosafety, molecular detection and serological diagnostics? Viruses 12 (7), 735. doi:&#xa0;10.3390/v12070735</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12070735</ArticleId><ArticleId IdType="pmc">PMC7412566</ArticleId><ArticleId IdType="pubmed">32646015</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M., Genovese M. (1992). Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins lupus cohort. J. Rheumatol 19 (10), 1559&#x2013;1565.</Citation><ArticleIdList><ArticleId IdType="pubmed">1464868</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf6;lkki A., Pekkarinen P. T., Takala J., Selander T., Reinikainen M. J. A. A. S. (2022). Association of sequential organ failure assessment (SOFA) components with mortality. Acta Anaesthesiol Scand. 66 (6), 731&#x2013;741. doi:&#xa0;10.1111/aas.14067</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.14067</ArticleId><ArticleId IdType="pmc">PMC9322581</ArticleId><ArticleId IdType="pubmed">35353902</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado C., de Paz B., L&#xf3;pez P., G&#xf3;mez J., Rodr&#xed;guez-Carrio J., Su&#xe1;rez A. J. C. (2013). Relationship between FOXP3 positive populations and cytokine production in systemic lupus erythematosus. Cytokine 61 (1), 90&#x2013;96. doi:&#xa0;10.1016/j.cyto.2012.08.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2012.08.033</ArticleId><ArticleId IdType="pubmed">23022375</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi S., Chen Q., Xu D., Xie N., Dai Y. (2018). Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis. Lupus 27 (10), 1582&#x2013;1590. doi:&#xa0;10.1177/0961203318773643</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318773643</ArticleId><ArticleId IdType="pubmed">29720035</ArticleId></ArticleIdList></Reference><Reference><Citation>Riccardi C., Bruscoli S., Migliorati G. (2002). Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacol. Res. 45 (5), 361&#x2013;368. doi:&#xa0;10.1006/phrs.2002.0969</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/phrs.2002.0969</ArticleId><ArticleId IdType="pubmed">12123623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricklin D., Reis E. S., Mastellos D. C., Gros P., Lambris J. D. (2016). Complement component C3-the &#x201c;Swiss army knife&#x201d; of innate immunity and host defense. Immunol. Rev. 274 (1), 33&#x2013;58. doi:&#xa0;10.1111/imr.12500</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12500</ArticleId><ArticleId IdType="pmc">PMC5427221</ArticleId><ArticleId IdType="pubmed">27782325</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigante D., Mazzoni M. B., Esposito S. (2014). The cryptic interplay between systemic lupus erythematosus and infections. Autoimmun Rev. 13 (2), 96&#x2013;102. doi:&#xa0;10.1016/j.autrev.2013.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2013.09.004</ArticleId><ArticleId IdType="pubmed">24051103</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S., Tan K. T. (2001). Pyrexia and normal c-reactive protein (CRP) in patients with systemic lupus erythematosus: Always consider the possibility of infection in febrile patients with systemic lupus erythematosus regardless of CRP levels. Rheumatol. (Oxford) 40 (3), 349&#x2013;350. doi:&#xa0;10.1093/rheumatology/40.3.349</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/40.3.349</ArticleId><ArticleId IdType="pubmed">11285392</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadaka F., EthmaneAbouElMaali C., Cytron M. A., Fowler K., Javaux V. M., O&#x2019;Brien J. (2017). Predicting mortality of patients with sepsis: A comparison of APACHE II and APACHE III scoring systems. J. Clin. Med. Res. 9 (11), 907. doi:&#xa0;10.14740/jocmr3083w</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jocmr3083w</ArticleId><ArticleId IdType="pmc">PMC5633090</ArticleId><ArticleId IdType="pubmed">29038667</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada T., Fujimori D., Yamamoto Y. (2019). Systemic lupus erythematosus and immunodeficiency. Immunol. Med. 42 (1), 1&#x2013;9. doi:&#xa0;10.1080/25785826.2019.1628466</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/25785826.2019.1628466</ArticleId><ArticleId IdType="pubmed">31204893</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B. K., Singh S. (2020). Systemic lupus erythematosus and infections. Reumatismo 72 (3), 154&#x2013;169. doi:&#xa0;10.4081/reumatismo.2020.1303</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/reumatismo.2020.1303</ArticleId><ArticleId IdType="pubmed">33213128</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P. P., Gordon C. (2010). Systemic lupus erythematosus: Clinical presentations. Autoimmun Rev. 10 (1), 43&#x2013;45. doi:&#xa0;10.1016/j.autrev.2010.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2010.08.016</ArticleId><ArticleId IdType="pubmed">20850569</ArticleId></ArticleIdList></Reference><Reference><Citation>Staples P. J., Gerding D. N., Decker J. L., Gordon R. S., Jr. (1974). Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 17 (1), 1&#x2013;10. doi:&#xa0;10.1002/art.1780170102</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780170102</ArticleId><ArticleId IdType="pubmed">4810662</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahren-Herlenius M., D&#xf6;rner T. (2013). Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382 (9894), 819&#x2013;831. doi:&#xa0;10.1016/S0140-6736(13)60954-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60954-X</ArticleId><ArticleId IdType="pubmed">23993191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Li M., Ye Z., Li C., Li Z., Li X., et al. . (2021). Long-term outcomes of patients with systemic lupus erythematosus: A multicenter cohort study from CSTAR registry. Rheumatol Immunol. Res. 2 (3), 195&#x2013;202. doi:&#xa0;10.2478/rir-2021-0025</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rir-2021-0025</ArticleId><ArticleId IdType="pmc">PMC9524789</ArticleId><ArticleId IdType="pubmed">36465068</ArticleId></ArticleIdList></Reference><Reference><Citation>Woldesemayat B., Gebremicael G., Zealiyas K., Yilma A., Adane S., Yimer M., et al. . (2022). Effect of heat inactivation for the detection of severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) with reverse transcription real time polymerase chain reaction (rRT-PCR): Evidence from Ethiopian study. BMC Infect. Dis. 22 (1), 1&#x2013;9. doi:&#xa0;10.1186/s12879-022-07134-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07134-7</ArticleId><ArticleId IdType="pmc">PMC8860295</ArticleId><ArticleId IdType="pubmed">35189815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>